I agree, Jeff. Obviously Generex isn’t in the good old boys club that Fauci supported. Things can change fast though as more adverse events from mrna style vaccines are reported. Joe made a hard corporate decision earlier in 2020 to put all limited resources into ngio. We knew, if we listened, that meant stalling all other endeavors so asking about revenue in the other subsidiaries means we aren’t listening. It’s all in place as those entities express faith in staying onboard to wait. But we are near that IND approval now as well as the IPO. Joe explained again to me today he DOES NOT want to over dilute at this level to raise a few million to ignite operations in Arizona etc. They do still expend a lot on rents there. He publicly said in the CC that he terminated the August 4 2020 L1 and Anston financing and have sent none of the warrants as it was too dilutive. He’s negotiating hard obviously on our behalf. It’s all in the CCs, of which we had many. It’s not perfect or as planned pre Covid, lack of funds hinder timelines obviously, but we actually are right there nearing stated goals for late March and April. I greatly hope in May we look back and say they did it.